Given the YAP-dependency of uveal melanoma, we investigated whether these cells would display increased sensitivity to MY-COMP-mediated YAP-B-MYB inhibition compared to B-RAF-mutated cell lines. This evidence concerns the gene MYBL2 and uveal melanoma.